Risk estimate produced from long-term BRCA gene study

05:46 EDT 22 Jun 2017 | Pharmafile

A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages when women are most at risk from cancer when they carry a faulty BRCA1 or BRCA2 gene.

The long-term study began in 1997 and was carried through to 2013, the study involved nearly 10,000 women exhibiting the genetic flaw. The ability to track when and, potentially, why women with the faulty would develop cancer allowed scientists to map when women were most vulnerable to cancer.

read more

Original Article: Risk estimate produced from long-term BRCA gene study


More From BioPortfolio on "Risk estimate produced from long-term BRCA gene study"

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...